TC011 / TiCARos - LARVOL DELTA

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients (clinicaltrials.gov) - P1/2 | N=98 | Recruiting | Sponsor: TICAROS Co., Ltd.

New P1/2 trial • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Primary Mediastinal Large B-Cell Lymphoma

TC011_FL_201: Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma (clinicaltrials.gov) - P2 | N=40 | Not yet recruiting | Sponsor: TICAROS Co., Ltd.

New P2 trial • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Oncology